CERT 241220 15.00C (CERT241220C15000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CERT241220C15000

Watchlist

2.54
0.000.00%

15min DelayTrading Nov 7 10:22 ET

0.00High0.00Low

Intraday

5D
Daily

News

Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3
Yahoo FinanceNov 13 09:29 ET
Express News | Certara Inc : Jefferies Cuts Target Price to $12.50 From $15.50
ReutersNov 11 00:37 ET
Capital Allocation Trends At Certara (NASDAQ:CERT) Aren't Ideal
Simply Wall StNov 8 09:32 ET
Baird Maintains Certara(CERT.US) With Hold Rating, Maintains Target Price $13
Moomoo NewsNov 8 03:33 ET · Ratings
Certara Hold Rating Maintained Amid Mixed Performance and Regulatory Concerns
TipRanksNov 8 02:29 ET · Ratings
Forecasting The Future: 4 Analyst Projections For Certara
BenzingaNov 7 12:00 ET

Comments

Moomoo AI

Mar 21 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet (FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin (APP.US)$
...